A Placebo-Controlled, Escalating Dose, Multiple Dose Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Pregabalin In Pediatric Patients With Partial Onset Seizures.
Phase of Trial: Phase I/II
Latest Information Update: 06 Nov 2014
At a glance
- Drugs Pregabalin (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions
- Sponsors Pfizer
- 29 Nov 2010 Additional location (France) identified as reported by ClinicalTrials.gov.
- 11 May 2010 Planned end date changed from 1 Dec 2010 to 1 Jul 2011 as reported by ClinicalTrials.gov.
- 05 May 2010 Additional location (South Korea) identified as reported by ClinicalTrials.gov.